Is this you? Create Your Porfile
Avatar

Durrant Steven

Vertex Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Durrant Steven is active.

Explore More

Publication

Featured researches published by Durrant Steven.

Archive | 2018

Pyrazinderivater anvendelige som inhibitorer til ATR kinase

Charrier Jean Damien; Durrant Steven; Kay David; Knegtel Ronald; Maccormick Somhairle; Mortimore Michael; O'donnell Michael; Pinder Joanne; Rutherford Alistair; Virani Anisa Nizarali; Young Stephen; Reaper Philip Michael

Archive | 2018

2-AMINO-6-FLUORO-N-(5-FLUORO-4-(4-(4-(OXETAN-3-YL)PIPERAZINE-1-CARBONYL)PIPERIDIN-1-YL)PYRIDIN-3-YL)PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMIDE AS INHIBITOR OF ATR KINASE

Ahmad Nadia; Boyall Dean; Charrier Jean-Damien; Davis Chris; Davis Rebecca; Durrant Steven; Etxebarria I Jardi Gorka; Fraysse Damien; Jimenez Juan-Miguel; Kay David; Knegtel Ronald; Middleton Donald; O'donnell Michael; Panesar Maninder; Pierard Francoise; Pinder Joanne; Shaw David; Storck Pierre-Henri; Studley John; Twin Heather

Archive | 2016

Métodos para preparar derivados de pirimidina útiles como inhibidores de proteína quinasa

Charrier Jean-Damien; Durrant Steven; O'donnell Michael

Archive | 2015

métodos para preparar os derivados de pirimidina úteis como inibidores de proteína cinase

Charrier Jean-Damien; O'donnell Michael; Durrant Steven

Archive | 2013

Processes for preparing ATR inhibitors

Pierard Francoise; Studley John R; Charrier Jean-Damien; Littler Benjamin; Hughes Robert; Siesel David; Angell Paul; Urbina Armando; Shi Yi; Durrant Steven

Archive | 2013

PYRID-2-ONE USEFUL AS TEC FAMILY PROTEIN KINASE INHIBITOR FOR TREATMENT OF INFLAMMATORY DISEASE, PROLIFERATIVE DISEASE AND IMMUNOLOGICALLY MEDIATED DISEASE

Charrier Jean-Damien; Durrant Steven; Ramaya Sharn; Jimenez Juan-Miguel; Rutherford Alistair

Archive | 2012

2-Alkylamino-7,8-dihydropteridin-6(5H)-one and 2-alkylamino-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one derivatives

Charrier Jean-Damien; Durrant Steven

Archive | 2012

Compounds useful as protein kinase inhibitors, particulary PLK1 protein kinases

Charrier Jean-Damien; Durrant Steven; Brenchley Guy; Mortimore Michael; Knegtel Ronald

Archive | 2012

3,5-DISUBSTITUIERTE PYRID-2-ONE, DIE SICH ALS INHIBITOREN DER TEC-FAMILIE VON NICHT-REZEPTOR- TYROSINKINASEN EIGNEN

Charrier Jean-Damien; Ramaya Sham; Durrant Steven

Archive | 2011

COMPUESTOS UTILES COMO INHIBIDORES DE PROTEINAS QUINASAS.

Knegtel Ronald; Durrant Steven; Brenchley Guy; Mortimore Michael; Charrier Jean-Damien

Explore More

Collaboration

Dive into the Durrant Steven's collaboration.

Top Co-Authors
Avatar

Charrier Jean-Damien

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Mortimore Michael

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Knegtel Ronald

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

O'donnell Michael

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Ramaya Sharn

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jimenez Juan-Miguel

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Studley John

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Kay David

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Pinder Joanne

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Pierard Francoise

Vertex Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge